-5%
Urofollitropin is utilized to stimulate egg production in women undergoing treatment for anovulatory infertility. Your doctor may prescribe multiple medications as part of a comprehensive pregnancy plan.
FSH 150IU IM/SC Injection contains Urofollitropin, classified under Gonadotropins, aiding in the production of adequate levels of estrogen, essential for conception.
Before commencing treatment, thorough fertility assessments for both partners are advisable. Continuous monitoring through blood tests and ultrasounds during treatment helps mitigate potential side effects.
Inform your doctor about any unexplained vaginal bleeding, clotting disorders, or brain, breast, uterine, or ovarian tumors before using FSH 150IU IM/SC Injection. Also, disclose fallopian tube damage, as this treatment may lead to ectopic pregnancy in such cases.
Avoid FSH 150IU IM/SC Injection during pregnancy post-conception, breastfeeding, and in individuals under 18 years due to insufficient safety data.
Common side effects may include hot flushes, abdominal pain, headache, and injection site reactions. Contact your doctor if symptoms worsen.